These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29158808)

  • 1. Distant Metastasis and Survival Outcomes after Computed Tomography-Guided Needle Biopsy in Resected Stage I-III Non-Small Cell Lung Cancer.
    Xi Y; Fan J; Che D; Zhai K; Ren T; Feng X; Shang L; Hu J; Yu Y; Meng Q
    J Cancer; 2017; 8(16):3356-3361. PubMed ID: 29158808
    [No Abstract]   [Full Text] [Related]  

  • 2. [Distant Metastasis and Survival Outcomes after Computed Tomography-guided Needle Biopsy in Stage I-II Non-small Cell Lung Cancer].
    Fan J; Zhai K; Ren T; Feng X; Sui L; Hu J; Meng Q
    Zhongguo Fei Ai Za Zhi; 2017 Mar; 20(3):187-191. PubMed ID: 28302221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence and disease-free survival outcomes after computed tomography-guided needle biopsy in stage IA non-small cell lung cancer patients in China: a propensity score matching analysis.
    He C; Yu H; Li C; Zhang X; Huang Z; Liu M; Tong L; Zhu J; Wu W; Huang X
    Quant Imaging Med Surg; 2021 Aug; 11(8):3472-3480. PubMed ID: 34341724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of pleural recurrence after computed tomography-guided needle biopsy in stage I lung cancer.
    Asakura K; Izumi Y; Yamauchi Y; Nakatsuka S; Inoue M; Yashiro H; Abe T; Sato Y; Nomori H
    PLoS One; 2012; 7(8):e42043. PubMed ID: 22876299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of EGFR mutation in pathologically non-malignant specimens from computed tomography-guided lung needle biopsies.
    Ueno T; Soh J; Hiraki T; Asano H; Ichimura K; Shibamoto K; Gobara H; Kanazawa S; Toyooka S; Miyoshi S
    Oncol Lett; 2012 Feb; 3(2):401-404. PubMed ID: 22740920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inaccuracy of lung adenocarcinoma subtyping using preoperative biopsy specimens.
    Huang KY; Ko PZ; Yao CW; Hsu CN; Fang HY; Tu CY; Chen HJ
    J Thorac Cardiovasc Surg; 2017 Jul; 154(1):332-339.e1. PubMed ID: 28366548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of pleural recurrence after computed tomographic-guided percutaneous needle biopsy in stage I lung cancer patients.
    Inoue M; Honda O; Tomiyama N; Minami M; Sawabata N; Kadota Y; Shintani Y; Ohno Y; Okumura M
    Ann Thorac Surg; 2011 Apr; 91(4):1066-71. PubMed ID: 21440124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate cytology improves accuracy and decreases complication rate in real-time computed tomography-guided needle lung biopsy.
    Tachibana K; Nakazato Y; Tsuchida S; Kazama T; Minato K; Yoshida T; Fujita A; Horikoshi H; Tanaka R; Iijima M; Goya T
    Diagn Cytopathol; 2013 Dec; 41(12):1063-8. PubMed ID: 23239643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Macroscopic Appearance of Computed Tomography-guided Needle Biopsy Specimens Correlates with Tumor Metastasis in Non-small Cell Lung Cancer.
    Toshiyuki N; Kimura T; Suzumura T; Yoshimoto N; Oka T; Yamamoto N; Matsuura K; Mitsuoka S; Asai K; Tochino Y; Yoshimura N; Kawaguchi T; Kudoh S; Matsuoka T; Ohsawa M; Hirata K
    Osaka City Med J; 2015 Dec; 61(2):105-12. PubMed ID: 26995854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence risk after preoperative biopsy in patients with resected early-stage non-small-cell lung cancer: a retrospective study.
    Hu C; Jiang J; Li Y; Zhang C; Zhang W; Jiang H; Gao Y; Zhuang W; Lei K; Tang Y; Wan R
    Cancer Manag Res; 2018; 10():1927-1934. PubMed ID: 30013399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive lung cancer staging: influence of CT-guided core needle biopsy on onset of pleural carcinomatosis.
    Flechsig P; Kunz J; Heussel CP; Bozorgmehr F; Schnabel P; Dienemann H; Kauczor HU; Sedlaczek O
    Clin Imaging; 2015; 39(1):56-61. PubMed ID: 25457543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous CT-guided fine needle aspiration for lung cancer smaller than 2 cm and revealed by ground-glass opacity at CT.
    Shimizu K; Ikeda N; Tsuboi M; Hirano T; Kato H
    Lung Cancer; 2006 Feb; 51(2):173-9. PubMed ID: 16378659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An accurate diagnosis of Noguchi classification is possible after the modification of preoperative biopsy-induced fibrosis.
    Nakajima Y; Kawamoto M; Koizumi K; Tajima H; Fukuda Y; Tsuchiya S; Shimizu K
    Ann Thorac Cardiovasc Surg; 2009 Aug; 15(4):221-6. PubMed ID: 19763052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of pleural recurrence after percutaneous transthoracic needle biopsy in stage I non-small-cell lung cancer.
    Ahn SY; Yoon SH; Yang BR; Kim YT; Park CM; Goo JM
    Eur Radiol; 2019 Jan; 29(1):270-278. PubMed ID: 29948086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management for chest wall implantation of non-small cell lung cancer after fine-needle aspiration biopsy.
    Kim JH; Kim YT; Lim HK; Kim YH; Sung SW
    Eur J Cardiothorac Surg; 2003 May; 23(5):828-32. PubMed ID: 12754041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic ultrasonography, fine-needle aspiration biopsy guided by endoscopic ultrasonography, and computed tomography in the preoperative staging of non-small-cell lung cancer: a comparison study.
    Gress FG; Savides TJ; Sandler A; Kesler K; Conces D; Cummings O; Mathur P; Ikenberry S; Bilderback S; Hawes R
    Ann Intern Med; 1997 Oct; 127(8 Pt 1):604-12. PubMed ID: 9341058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Volume-Based Assessment With 18F-FDG PET/CT Improves Outcome Prediction for Patients With Stage IIIA-N2 Non-Small Cell Lung Cancer.
    Hyun SH; Ahn HK; Ahn MJ; Ahn YC; Kim J; Shim YM; Choi JY
    AJR Am J Roentgenol; 2015 Sep; 205(3):623-8. PubMed ID: 26295651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
    Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability of Small Biopsy Samples Compared With Resected Specimens for the Determination of Programmed Death-Ligand 1 Expression in Non--Small-Cell Lung Cancer.
    Kitazono S; Fujiwara Y; Tsuta K; Utsumi H; Kanda S; Horinouchi H; Nokihara H; Yamamoto N; Sasada S; Watanabe S; Asamura H; Tamura T; Ohe Y
    Clin Lung Cancer; 2015 Sep; 16(5):385-90. PubMed ID: 25937270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of stereotactic body radiation therapy for biopsy-proven versus radiographically diagnosed early-stage non-small lung cancer: a single-institution experience.
    Fischer-Valuck BW; Boggs H; Katz S; Durci M; Acharya S; Rosen LR
    Tumori; 2015; 101(3):287-93. PubMed ID: 25908031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.